Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity.

業績番号：2023-2

A.Gravina, G.Tediashbili, Y.Zheng, K.A.Iwabuchi, S.M.Peyrot, S.Z.Roodsari, L.Gargiulo, S.Kaneko, M.Osawa, S.Schrepfer and T.Deuse.

Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity.

Cell Stem Cell 30(11); 1538:1548.e4; 2023.11.2

37922880

https://doi.org/10.1016/j.stem.2023.10.003